Overexpression of IRF-1 enhanced the chemosensitivity of gastric cancer cells to 5-fluorouracil [39], and high expression of IRF-1 also improved the efficiency of cisplatin-mediated killing of ovarian [40] and pancreatic cancer cells [41]. The gene discussed is IRF1; the disease is pancreatic neoplasm.